Abstract
A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have